As expected, LPS increased the nuclear expression of both NF-κB and FoxO1a, leading to the upregulation of UPS- and ALS-related molecules, including atrogin-1, MuRF1, and LC3B-II/I. Here, FBXO32 is linked to amyotrophic lateral sclerosis.